NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The class action lawsuit filed Monday claims the utility caused Sunset District businesses significant financial harm during a series of outages around the holidays.Read More